Skip to content

Applied research in children with spastic cerebral palsy in the extracorporeal shock wave therapy

Applied research in children with spastic cerebral palsy in the extracorporeal shock wave therapy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCC-15006095
Enrollment
Unknown
Registered
2015-03-14
Start date
2015-04-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

spastic cerebral palsy

Interventions

Case series:Nil

Sponsors

First Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 16 Years

Inclusion criteria

Inclusion criteria: 1. comply with spastic cerebral palsy diagnostic criteria; 2. age 1 month to 16 years; 3. the causes of cerebral palsy are common causes; 4. the informed consent of patients or their families who accept this clinical trial.

Exclusion criteria

Exclusion criteria: 1. not meet the above diagnostic criteria and inclusion criteria; 2. severe heart disease, arrhythmias, or have serious medical conditions such as heart, lung, liver, kidney and other vital organ dysfunction; 3. bleeding disorders, coagulation disorders; 4. fitted with a pacemaker patients; 5. thrombosis; 6. in critical condition, it is difficult to make the evaluator to the efficacy and safety; 7. the patient or the patient guardian refuse treatment; 8. the treatment site tendon and fascia acute injury; 9. penetrate the synovial fluid of patients; the presence of 10. the treatment site atrophy and infected nonunion; exist 11. the treatment site segmental bone defects nonunion.

Design outcomes

Primary

MeasureTime frame
Muscle thickness;Joint activity;Evaluation of muscle tension;Gross Motor Function Measure Scale;

Contacts

Public ContactJia Feiyong
erkekangfujia@163.com+86 13943003914

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026